SCHEMBL26041591

SCHEMBL26041591

N#Cc1ccc(-c2ccc(-n3c4ccc(-c5ccccc5)cc4c4cc(-c5ccccc5)ccc43)cc2-c2nc(-c3ccc(-c4cccc(C#N)c4)cc3)nc(-c3cc(-n4c5ccc(-c6ccccc6)cc5c5cc(-c6ccccc6)ccc54)ccc3-c3ccc(C#N)cc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.41
CYP3A4 P08684 6/20 0.41
MEN1 O00255 4/20 0.41
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 4/20 0.41
LMNA P02545 4/20 0.41
CYP2D6 P10635 4/20 0.41
TSHR P16473 3/20 0.41
CYP2C19 P33261 3/20 0.41
CLK4 Q9HAZ1 3/20 0.41
HSD17B10 Q99714 3/20 0.41
CYP2C9 P11712 2/20 0.41
ALDH1A3 P47895 1/20 0.39
MAPK1 P28482 2/20 0.39
ABCG2 Q9UNQ0 5/20 0.38
TP53 P04637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
ABCB1 P08183 2/20 0.38
PGR P06401 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26041605 0.97 CYP1A2 (0.40) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL26054263 0.97 CYP1A2 (0.40) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL26056850 0.96 CYP1A2 (0.42) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL26041596 0.96 ABCG2 (0.41) ALDH1A3ABCG2ABCB1PGRAKT1
SCHEMBL26057132 0.95 CYP1A2 (0.40) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL26057283 0.95 ALDH1A3 (0.39) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL26041612 0.95 ALDH1A3 (0.39) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL26053528 0.95 CYP1A2 (0.40) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL26054167 0.94 ALDH1A3 (0.38) CYP1A2CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL26054326 0.94 CYP1A2 (0.40) CYP1A2CYP3A4MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES TYR, WIZ, NR2E3 CYP1A2 236/4885CYP3A4 434/4885MEN1 4635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.